Over 2,000 patients participating in study in seven months
California center will combine research and commercial production
Actual patient outcomes not representative of staffers' culture perceptions
Yields almost 20 percent more5-year survival benefit
Advancements in image-guided therapies are needed
250,000 men per year may avoid unnecessary biopsies
Sizing up tomosynthesis and MR as breast imaging solutions
Might be part of the early pathology of the condition
State's 'brave stand' lauded by health care stakeholders
The Minicare I-20 takes less than 10 minutes
By 2021, MR providers may no longer depend on non-renewable gas
Should the UK start a national screening program?
Has tubes and detectors business been holding back oncology group?
Automating care provider safety recommendations
An up-close look at a booming industry
Fitness tracker reportedly off by as many as 20-30 bpms
Fourth deal of its kind this year for Philips
Designed to reduce medication errors while increasing cybersecurity
First breast tomosynthesis system cleared for use without 2-D mammo
Dose changes (titrations) create more room for error
Part of new trial investigating efficacy
Crowd-sourcing toward best practices
Mounting evidence of cardiac MR's many benefits
Four collaborations over the next five years set sights on low survival indications
Fighting addiction with increased activity in the prefrontal cortex
T807 may hold key to understanding Alzheimer's
Progress on the road to U.S. production of SPECT's workhorse isotope
Reducing uncertainty around implantable defibrillators
Anorectal malformations affect one in 5,000 babies
New research may propel FDA clearance, estimated for June 1
Part of a trend toward managed equipment service agreements
Accurately distinguishes healthy and diseased tissue
Using less contrast agent to obtain equivalent images
Multiple layers of retrospective, diagnostic data in a single, low-dose scan
The fourth recall for the company since July 2015
40 percent of patients with CRT-Ds will need MR exams
Company could make $2 billion in deal
Five more expected to join by end of summer
Allows better planning and navigation during brain and spine surgeries
Catching more lesions while lowering the recall rate
A more customized approach to patient care
Includes first MR-conditional passive fixation lead approved in U.S.
3-D device market expected to reach over $2 billion by 2020
Reimbursement for brain MR has dropped 45 percent in recent years
ACO Partner is a payor-neutral company that interacts with diverse health segments
Vevo MD from Fujifilm VisualSonics has resolution down to 30 micrometers
French hospital reduces mortality with technology
New promise emerging for SBRT on larger tumors
Noninvasive option may improve screening compliance rates
Study finds outcomes significantly better when treated within 2.5 hours